Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IL18BP | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
mRNA | PPIG | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | SASH3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | FAM168A | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | RP11-293I14.2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | COQ3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | CD93 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | DCAF5 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | UBXN8 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | BICD1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |